SCHEMBL7241983

SCHEMBL7241983

O=C(NC(CO)Cc1ccccc1)c1cccnc1N1CCN(c2ccncc2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 4/20 0.64
CTSS P25774 2/20 0.64
ROCK2 O75116 4/20 0.52
ROCK1 Q13464 4/20 0.52
RPS6KA5 O75582 2/20 0.52
RPS6KA4 O75676 2/20 0.52
PRKACA P17612 2/20 0.52
MAPK1 P28482 2/20 0.52
GSK3B P49841 2/20 0.52
PRKX P51817 2/20 0.52
PRKG1 Q13976 2/20 0.52
CLK4 Q9HAZ1 2/20 0.52
GSK3A P49840 1/20 0.52
IRAK1 P51617 1/20 0.52
PKN2 Q16513 1/20 0.52
SGK2 Q9HBY8 1/20 0.52
LIMK1 P53667 1/20 0.51
TSHR P16473 1/20 0.48
HSD17B10 Q99714 1/20 0.48
HTR1A P08908 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7243622 0.95 CAPN1 (0.70) CAPN1CTSSROCK2ROCK1RPS6KA5
SCHEMBL7233164 0.90 CAPN1 (0.62) CAPN1CTSSROCK2ROCK1RPS6KA5
SCHEMBL7239751 0.89 CAPN1 (0.59) CAPN1CTSSROCK2ROCK1RPS6KA5
SCHEMBL7241202 0.88 CHIA (0.59) CAPN1CTSSROCK2ROCK1RPS6KA5
SCHEMBL7242740 0.87 CAPN1 (0.57) CAPN1CTSSROCK2ROCK1RPS6KA5
SCHEMBL7232925 0.86 CAPN1 (0.59) CAPN1CTSSROCK2ROCK1RPS6KA5
SCHEMBL7243109 0.86 CAPN1 (0.56) CAPN1CTSSROCK2ROCK1RPS6KA5
SCHEMBL7242752 0.85 CAPN1 (0.63) CAPN1CTSSTSHRHSD17B10KDM4E
SCHEMBL7235665 0.84 CAPN1 (0.55) CAPN1CTSSROCK2ROCK1RPS6KA5
SCHEMBL7238990 0.83 CAPN1 (0.54) CAPN1CTSSROCK2ROCK1RPS6KA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562827-B1 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages ABBOTT LABORATORIES 2003-05-13 US disclosed